BRAINLIFE Brain Tumor Medical Database

Carboplatin

Home > Database > Treatment > Carboplatin (CBDCA)

Contents


Embryonal Tumors


Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R, Milano GM, Garrè ML, Donfrancesco A
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience
J Neurooncol. 2009 Apr;92(2):177-83. Epub 2008 Nov 29
  Abstract


Germ Cell Tumors


Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53


Gliofibroma


C. R. Suarez, S. J. Bertolone
Carboplatinum (CBDCA), vincristine (V) therapy for CNS gliofibroma
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 461


Gliomas (Low-Grade)


Lafay-Cousin L, Holm S, Qaddoumi I, Nicolin G, Bartels U, Tabori U, Huang A, Bouffet E
Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction
Cancer. 2005 Apr 28; [Epub ahead of print]

Ronghe M, Hargrave D, Bartels U, Tabori U, Vaidya S, Chandler C, Kulkarni A, Bouffet E.
Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem
Pediatr Blood Cancer. 2010 May 26;. [Epub ahead of print]
  Abstract

Sridharan Gururangan, Christina M. Cavazos, David Ashley, James E. Herndon, II, Carol S. Bruggers, Albert Moghrabi, Deborah L. Scarcella, Melody Watral, Sandra Tourt-Uhlig, David Reardon, Henry S. Friedman
Phase II Study of Carboplatin in Children With Progressive Low-Grade Gliomas
. (Abstract+)


Medulloblastoma


F. Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P. Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival results in adults treated for medulloblastoma
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 479


Metastatic Tumors


D. Y. Kim, K. W. Lee, T. Yun, J. H. Kim, D. W. Kim, S. A. Im, T. Y. Kim, D. S. Heo, Y. J. Bang, N. K. Kim
Efficacy of platinum-based chemotherapy after cranial irradiation in patients with brain metastasis from non-small cell lung cancer
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1575

Jane W. Marsh, Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January 2004

Robert Morgan Jr., Timothy Synold, Adam Mamelak, Kim Margolin, Al-Kadhimi Zaid, Przemyslaw Twardowski, Lucille Leong, Dean Lim, Sandeep Reddy, Isan Chen, Warren Chow, Stephen Shibata, George Somlo, Yun Yen, Paul Frankel, James H Doroshow
Phase I trial of tamoxifen (Tam), carboplatin (C), and topotecan (T) in recurrent or metastatic brain tumors
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No. 2102



Oligod. T. & Mixed Gliomas


U. Basso, F. Vastola, L. M. Pasetto, A. Scola, M. Ermani, M. Cacciacarne, F. Sala, A. Talacchi, M. K. Paris, A. A. Brandes
Carboplatin and VM-26 as third-line chemotherapy in patients with oligodendroglioma refractory to PCV and temozolomide
3
9th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 433

A. A. Brandes, U. Basso, F. Vastola, A. Tosoni, L. M. Pasetto, A. Jirillo, S. Lonardi, M. K. Paris, H. Koussis, S. Monfardini and M. Ermani
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study
Annals of Oncology 14:1727-1731, December 2003

L. Scopece, G. Cavallo, E. Palmerini, E. Franceschi, A. Paioli, F. Spagnolli, S. Rimondini, R. Conforti, R. Degli Esposti, L. Crino
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1562

Soffietti R, Nobile M, Ruda R, Borgognone M, Costanza A, Laguzzi E, Mutani R
Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study
Cancer. 2004 Feb 15;100(4):807-13

 

This website is certified by Health On the Net Foundation. Click to verify. HOMEARCHIVES OF NEURO-ONCOLOGYCURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTS
SERVICES: About BrainLife | Brain Tumor Medical Database | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications

This site complies with the HONcode standard for trustworthy health information: verify here bottom